Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@AmericanBanking 12
@Tickeron 10
@TheMarketsDaily 8
@ConsumerFeed 8
@WeekHerald 7

Recent Tweets for FATE

gcassidy718 @gcassidy718
$FATE considerable price movement 4.18 % change recently https://t.co/rJRHk0DOAl
November 17th 2019, 4:11am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Rating Lowered to Buy at ValuEngine https://t.co/oThMSlsCdJ
November 17th 2019, 2:11am
OlympiaReport @OlympiaReport
Fate Therapeutics $FATE Coverage Initiated at SunTrust Banks https://t.co/MHd5YRZmpE
November 16th 2019, 8:11pm
TickerReport @TickerReport
Fate Therapeutics $FATE Receives New Coverage from Analysts at SunTrust Banks https://t.co/g7f3bii6Fc
November 16th 2019, 8:11pm
WatchlistN @WatchlistN
Fate Therapeutics $FATE Receives New Coverage from Analysts at SunTrust Banks https://t.co/E3pmzVpfFH
November 16th 2019, 8:11pm
TheMarketsDaily @TheMarketsDaily
Fate Therapeutics $FATE Stock Rating Lowered by ValuEngine https://t.co/51ZtSC1OaA
November 16th 2019, 4:11pm
Gambiste1 @Gambiste1
RT @IlliniJJ: $FATE - good to see On November 13, 2019, Fate Therapeutics repaid in full all outstanding obligations under the Loan Agreem…
November 15th 2019, 10:11pm
Tickeron @Tickeron
$FATE in Uptrend: price expected to rise as it breaks its lower Bollinger Band on November 6, 2019. View odds for t… https://t.co/Tvb7OHLtDI
November 15th 2019, 7:11pm
BlueBioNow @BlueBioNow
$FATE substantial stock price changes 3.26 % change recently https://t.co/BXYgVAHbXB
November 15th 2019, 3:11pm
1stOncology @1stOncology
#FateTherapeutics to Present at the Jefferies 2019 London #HealthcareConference $FATE https://t.co/SIrMS2acAt
November 15th 2019, 6:11am
dhovekamp42 @dhovekamp42
RT @otcdynamics: $FATE Fate Therapeutics to Present at the Jefferies 2019 London Healthcare Conference https://t.co/msJUtUgJB6
November 15th 2019, 2:11am
IlliniJJ @IlliniJJ
$FATE - good to see On November 13, 2019, Fate Therapeutics repaid in full all outstanding obligations under the L… https://t.co/LJf2GfEgkG
November 14th 2019, 8:11pm
BlueBioNow @BlueBioNow
$FATE I’ll probably buy on the dip. Still need to do more research. -4.45 % https://t.co/BXYgVApB63
November 14th 2019, 7:11pm
otcdynamics @otcdynamics
$FATE Fate Therapeutics to Present at the Jefferies 2019 London Healthcare Conference https://t.co/msJUtUgJB6
November 14th 2019, 4:11pm
Tickeron @Tickeron
$FATE in Downtrend: Stochastic indicator leaves overbought zone. View odds for this and other indicators:… https://t.co/veY36rw1xe
November 13th 2019, 6:11pm
BlueBioNow @BlueBioNow
$FATE definitely going to finish over $16.65 4.38 % change recently https://t.co/BXYgVAHbXB
November 12th 2019, 2:11pm
WeekHerald @WeekHerald
Fate Therapeutics $FATE Research Coverage Started at SunTrust Banks https://t.co/7hhWkW1PPb
November 12th 2019, 10:11am
ThisLincolnian @ThisLincolnian
Fate Therapeutics $FATE Research Coverage Started at SunTrust Banks https://t.co/YgGWeoRkNM
November 12th 2019, 10:11am
AmericanBanking @AmericanBanking
Fate Therapeutics $FATE Research Coverage Started at SunTrust Banks https://t.co/rItvC3erNi #stocks
November 12th 2019, 9:11am
dhovekamp42 @dhovekamp42
RT @Quantumup1: $FATE initiated with a Buy rating, $25 PT at SunTrust https://t.co/7asnIOIe3P
November 12th 2019, 8:11am
Quantumup1 @Quantumup1
$FATE initiated with a Buy rating, $25 PT at SunTrust https://t.co/7asnIOIe3P
November 12th 2019, 8:11am
dhovekamp42 @dhovekamp42
RT @stockhoot: $FATE SunTrust Robinson Humphrey Initiates Coverage On to Buy : PT $25.00 https://t.co/609DW5cERr
November 12th 2019, 7:11am
stockhoot @stockhoot
$FATE SunTrust Robinson Humphrey Initiates Coverage On to Buy : PT $25.00 https://t.co/609DW5cERr
November 12th 2019, 6:11am
MrKenn14 @MrKenn14
SunTrust Robinson Humphrey Initiates Coverage On Fate Therapeutics with Buy Rating, Announces $25 Price Target $FATE
November 12th 2019, 6:11am
dakotafinancial @dakotafinancial
Wedbush Analysts Raise Earnings Estimates for Fate Therapeutics Inc $FATE https://t.co/nUnVtRkctT
November 12th 2019, 2:11am
OnlyBios @OnlyBios
2) There’s $FATE which raises when their stock price is high. They raised once below $3 but that’s when they needed… https://t.co/Fs8a2rC8Qg
November 11th 2019, 7:11pm
Tickeron @Tickeron
$FATE in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/iv4m0xkAIj
November 11th 2019, 6:11pm
TranscriptDaily @TranscriptDaily
Wedbush Brokers Boost Earnings Estimates for Fate Therapeutics Inc $FATE https://t.co/CzngEaf5MD
November 11th 2019, 3:11am
TheMarketsDaily @TheMarketsDaily
Fate Therapeutics Inc to Post FY2019 Earnings of -$1.48 Per Share, Svb Leerink Forecasts $FATE https://t.co/hLcOIQjHrN
November 11th 2019, 3:11am
EnterpriseLeade @EnterpriseLeade
FY2019 Earnings Estimate for Fate Therapeutics Inc Issued By Wedbush $FATE https://t.co/ibTkzy22Vt
November 11th 2019, 3:11am
stocknewstimes @stocknewstimes
Fate Therapeutics Inc to Post FY2019 Earnings of -$1.48 Per Share, Svb Leerink Forecasts $FATE https://t.co/9qkI1swkMb
November 11th 2019, 3:11am
dakotafinancial @dakotafinancial
Fate Therapeutics $FATE Lowered to Hold at Zacks Investment Research https://t.co/lyuaSykmIO
November 11th 2019, 12:11am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Downgraded to Hold at Zacks Investment Research https://t.co/uysy2HE1eI
November 11th 2019, 12:11am
dispatchtribune @dispatchtribune
Fate Therapeutics Inc $FATE Expected to Announce Quarterly Sales of $1.81 Million https://t.co/MM5KpW4EGV
November 10th 2019, 8:11pm
EnterpriseLeade @EnterpriseLeade
$1.81 Million in Sales Expected for Fate Therapeutics Inc $FATE This Quarter https://t.co/ZM1AMBdBxB
November 10th 2019, 8:11pm
dakotafinancial @dakotafinancial
Zacks: Brokerages Anticipate Fate Therapeutics Inc $FATE Will Post Earnings of -$0.39 Per Share https://t.co/tBLhcTON18
November 10th 2019, 7:11pm
Tickeron @Tickeron
$FATE in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/spyhZtTjZT
November 10th 2019, 6:11pm
WeekHerald @WeekHerald
Fate Therapeutics $FATE Stock Rating Lowered by Wells Fargo & Co https://t.co/MW9wqWxhYu
November 10th 2019, 2:11pm
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Stock Rating Lowered by Mizuho https://t.co/Y59D6gbiRx
November 10th 2019, 12:11pm
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Stock Rating Lowered by Mizuho https://t.co/8uVK711w3f
November 10th 2019, 12:11pm
dakotafinancial @dakotafinancial
BMO Capital Markets Lowers Fate Therapeutics $FATE Price Target to $26.00 https://t.co/pr0DgFOB7a
November 10th 2019, 11:11am
OlympiaReport @OlympiaReport
Piper Jaffray Companies Comments on Fate Therapeutics Inc’s FY2019 Earnings $FATE https://t.co/unAy80QKYW
November 10th 2019, 6:11am
ConsumerFeed @ConsumerFeed
FY2019 Earnings Forecast for Fate Therapeutics Inc Issued By Jefferies Financial Group $FATE https://t.co/6m5WTsivdn
November 10th 2019, 6:11am
TranscriptDaily @TranscriptDaily
FY2019 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/P1raAAUD26
November 10th 2019, 6:11am
ThisLincolnian @ThisLincolnian
Fate Therapeutics Inc to Post FY2019 Earnings of -$1.48 Per Share, Cantor Fitzgerald Forecasts $FATE https://t.co/OJnYs9VnaW
November 10th 2019, 6:11am
stocknewstimes @stocknewstimes
FY2019 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/VLh2Txf67p
November 10th 2019, 6:11am
newsfilterio @newsfilterio
Fate Therapeutics Announces Six Presentations at the 2019 ASH Annual Meeting $FATE https://t.co/44cxnlaZsV
November 10th 2019, 4:11am
AmericanBanking @AmericanBanking
Fate Therapeutics Inc $FATE Given Average Rating of “Buy” by Brokerages https://t.co/o2yZD1Q0Oe #stocks
November 10th 2019, 1:11am
dailypoliticaln @dailypoliticaln
Fate Therapeutics Inc $FATE Receives Average Recommendation of “Buy” from Analysts https://t.co/7elqZYhkca
November 10th 2019, 1:11am
TickerReport @TickerReport
Fate Therapeutics Inc $FATE Given Average Rating of “Buy” by Brokerages https://t.co/px6eFtnJkP
November 10th 2019, 1:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.